MedPath

Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki University

Not Applicable
Recruiting
Conditions
Early arthritis
Registration Number
JPRN-UMIN000014881
Lead Sponsor
agasaki University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

1. Under twenty years old 2. Non-RA rheumatic diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Progression rate of definitive RA from early arthritis after treatment for 12 months 2. SDAI remission rate and no radiographic progression rate 3.HAQ remission rate 4. Musculoskeletal ultrasonography remission rate (Total Power Doppler score <2)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath